Preventing Needlestick Injuries in Health Care Settings
To receive documents or more information about occupational safety and health topics, contact the National Institute for Occupational Safety and Health (NIOSH) at
4676 Columbia Parkway
Cincinnati, OH 45226-1998
or visit the NIOSH Web site at http://www.cdc.gov/niosh/homepage.html
Health care workers who use or may be exposed to needles are at increased risk of needlestick injury. Such injuries can lead to serious or fatal infections with bloodborne pathogens such as hepatitis B virus, hepatitis C virus, or human immunodeficiency virus (HIV).
Employers of health care workers should implement the use of improved engineering controls to reduce needlestick injuries:
Needlestick injuries can best be reduced when the use of improved engineering controls is incorporated into a comprehensive program involving workers. Employers should implement the following program elements:
Health care workers should take the following steps to protect themselves and their fellow workers from needlestick injuries:
For additional information, see NIOSH Alert: Preventing Needlestick Injuries in Health Care Settings [DHHS (NIOSH) Publication 2000-108]. Single copies of the Alert are available free from the following:
4676 Columbia Parkway
Cincinnati, OH 45226-1998
Public Health Service
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health
Health care workers who use or may be exposed to needles are at increased risk of needlestick injury. Such injuries can lead to serious or fatal infections with bloodborne pathogens such as hepatitis B virus, hepatitis C virus, or human immunodeficiency virus (HIV).
The National Institute for Occupational Safety and Health (NIOSH) requests
assistance in preventing needlestick injuries among health care workers.* These
injuries are caused by needles such as hypodermic needles, blood collection
needles, intravenous (IV) stylets, and needles used to connect parts of IV
delivery systems. These injuries may cause a number of serious and potentially
fatal infections with bloodborne pathogens such as hepatitis B virus (HBV),
hepatitis C virus (HCV), or human immunodeficiency virus (HIV)—the virus that
causes acquired immunodeficiency syndrome (AIDS).
These injuries can be avoided by eliminating the unnecessary use of needles, using devices with safety features, and promoting education and safe work practices for handling needles and related systems. These measures should be part of a comprehensive program to prevent the transmission of bloodborne pathogens.
This Alert provides current scientific information about the risk of needlestick injury and the transmission of bloodborne pathogens to health care workers. The document focuses on needlestick injuries as a key element in a broader effort to prevent all sharps-related injuries and associated bloodborne infections. The document describes five cases of health care workers with needlestick-related infections and presents intervention strategies for reducing these risks. Because many needleless devices and safer needle devices have been recently introduced and the field is rapidly evolving, the Alert briefly describes an approach for evaluating these devices.
NIOSH requests that workers, employers, manufacturers, editors of professional journals, safety and health officials, and labor unions implement the recommendations in this Alert and bring them to the attention of all health care workers who use or may be exposed to needles in the workplace.
More than 8 million health care workers in the United States work in hospitals and other health care settings. Precise national data are not available on the annual number of needlestick and other percutaneous injuries among health care workers; however, estimates indicate that 600,000 to 800,000 such injuries occur annually [Henry and Campbell 1995; EPINet 1999]. About half of these injuries go unreported [Roy and Robillard 1995; EPINet 1999; CDC 1997a; Osborn et al. 1999]. Data from the EPINet system suggest that at an average hospital, workers incur approximately 30 needlestick injuries per 100 beds per year [EPINet 1999].
Most reported needlestick injuries involve nursing staff; but laboratory staff, physicians, housekeepers, and other health care workers are also injured. Some of these injuries expose workers to bloodborne pathogens that can cause infection. The most important of these pathogens are HBV, HCV, and HIV. Infections with each of these pathogens are potentially life threatening—and preventable.
The emotional impact of a needlestick injury can be severe and long lasting, even when a serious infection is not transmitted. This impact is particularly severe when the injury involves exposure to HIV. In one study of 20 health care workers with an HIV exposure, 11 reported acute severe distress, 7 had persistent moderate distress, and 6 quit their jobs as a result of the exposure [Henry et al. 1990]. Other stress reactions requiring counseling have also been reported [Armstrong et al. 1995]. Not knowing the infection status of the source patient can accentuate the health care workers stress. In addition to the exposed health care worker, colleagues and family members may suffer emotionally.
Between 1985 and June 1999, cumulative totals of 55 "documented"†
cases and 136 "possible"‡ cases of occupational HIV transmission to
U.S. health care workers were reported to the Centers for Disease Control and
Prevention (CDC) [CDC 1998a]. Most involved nurses and laboratory technicians.
Percutaneous injury (e.g., needlestick) was associated with 49 (89%) of the
documented transmissions. Of these, 44 involved hollow-bore needles, most of
which were used for blood collection or insertion of an IV catheter.
HIV infection is a complex disease that can be associated with many symptoms. The virus attacks part of the bodys immune system, eventually leading to severe infections and other complications—a condition known as AIDS. Despite current therapies that delay the progression of HIV disease, most health care workers who become infected with HIV are likely to eventually develop AIDS and die.
Information from national hepatitis surveillance is used to estimate the
number of HBV infections in health care workers. In 1995, an estimated 800
health care workers became infected with HBV [CDC unpublished data]. This figure
represented a 95% decline from the 17,000 new infections estimated in 1983. The
decline was largely due to the widespread immunization of health care workers
with the hepatitis B vaccine and the use of universal precautions and other
measures required by the Occupational Safety and Health Administration (OSHA)
bloodborne pathogens standard [29 CFR§ 1910.1030].
About one-third to one-half of persons with acute HBV infection develop symptoms of hepatitis such as jaundice, fever, nausea, and abdominal pain. Most acute infections resolve, but 5% to 10% of patients develop chronic infection with HBV that carries an estimated 20% lifetime risk of dying from cirrhosis and 6% risk of dying from liver cancer [Shapiro 1995].
Hepatitis C virus infection is the most common chronic bloodborne infection in the United States, affecting approximately 4 million people [CDC 1998b]. Although the prevalence of HCV infection among health care workers is similar to that in the general population (1% to 2%) [CDC 1998b], health care workers clearly have an increased occupational risk for HCV infection. In a study that evaluated risk factors for infection, a history of unintentional needlestick injury was independently associated with HCV infection [Polish et al. 1993]. The number of health care workers who have acquired HCV occupationally is not known. However, of the total acute HCV infections that have occurred annually (ranging from 100,000 in 1991 to 36,000 in 1996), 2% to 4% have been in health care workers exposed to blood in the workplace [Alter 1995, 1997; CDC unpublished data].
HCV infection often occurs with no symptoms or only mild symptoms. But unlike HBV, chronic infection develops in 75% to 85% of patients, with active liver disease developing in 70%. Of the patients with active liver disease, 10% to 20% develop cirrhosis, and 1% to 5% develop liver cancer [CDC 1998b].
RISK OF INFECTION AFTER A NEEDLESTICK INJURY
After a needlestick exposure to an infected patient, a health care worker's risk of infection depends on the pathogen involved, the immune status of the worker, the severity of the needlestick injury, and the availability and use of appropriate post-exposure prophylaxis.
To estimate the rate of HIV transmission, data were combined from more than 20 worldwide prospective studies of health care workers exposed to HIV-infected blood through a percutanous injury. In all, 21 infections followed 6,498 exposures for an average transmission rate of 0.3% per injury [Gerberding 1994; Ippolito et al. 1999]. A retrospective case-control study of health care workers who had percutaneous exposures to HIV found that the risk of HIV transmission was increased when the worker was exposed to a larger quantity of blood from the patient, as indicated by (1) a visibly bloody device, (2) a procedure that involved placing a needle in a patient's vein or artery, or (3) a deep injury [Cardo et al. 1997]. Preliminary data suggest that such high-risk needlestick injuries may have a substantially greater risk of disease transmission per injury [Bell 1997].
Post-exposure prophylaxis for HIV is recommended for health care workers occupationally exposed to HIV under certain circumstances [CDC 1998c]. Limited data suggest that such prophylaxis may considerably reduce the chance of becoming infected with HIV [Cardo et al. 1997]. However, the drugs used for HIV post-exposure prophylaxis have many adverse side effects [CDC 1998c]. Currently no vaccine exists to prevent HIV infection, and no treatment exists to cure it [CDC 1998d].
The rate of HBV transmission to susceptible health care workers ranges from 6% to 30% after a single needlestick exposure to an HBV-infected patient [CDC 1997b]. However, such exposures are a risk only for health care workers who are not immune to HBV. Health care workers who have antibodies to HBV either from pre-exposure vaccination or prior infection are not at risk. In addition, if a susceptible worker is exposed to HBV, post-exposure prophylaxis with hepatitis B immune globulin and initiation of hepatitis B vaccine is more than 90% effective in preventing HBV infection.
Prospective studies of health care workers exposed to HCV through a needlestick or other percutaneous injury have found that the incidence of anti-HCV seroconversion (indicating infection) averages 1.8% (range, 0% to 7%) per injury [Alter 1997; CDC 1998b]. Currently no vaccine exists to prevent HCV infection, and neither immunoglobulin nor antiviral therapy is recommended as post-exposure prophylaxis [CDC 1998b]. However, recommendations for treatment of early infections are rapidly evolving. Health care workers with known exposure should be monitored for seroconversion and referred for medical follow-up if seroconversion occurs.
Although exposure to HBV poses a high risk for infection, administration of pre-exposure vaccination or post-exposure prophylaxis to workers can dramatically reduce this risk. Such is not the case with HCV and HIV. Preventing the needlestick injury is the best approach to preventing these diseases in health care workers, and it is an important part of any bloodborne pathogen prevention program in the workplace.
HOW DO NEEDLESTICK INJURIES OCCUR?
Devices Associated with Needlestick Injuries
Health care workers use many types of needles and other sharp devices to provide patient care. However, data from hospitals participating in the CDC National Surveillance System for Hospital Health Care Workers (NaSH) and from hospitals included in the EPINet research database show that only a few needles and other sharp devices are associated with the majority of injuries [International Health Care Worker Safety Center 1997; EPINet 1999; CDC unpublished data 1999]. Of nearly 5,000 percutaneous injuries reported by hospitals participating in NaSH between June 1995 and July 1999, 62% were associated with hollow-bore needles—primarily hypodermic needles attached to disposable syringes (29%) and winged-steel (butterfly-type) needles (13%). Figure 1 shows the extent to which these and other sharp devices contributed to the burden of percutaneous injuries in NaSH hospitals. Data from hospitals participating in EPINet show a similar distribution of injuries by device type [EPINet 1999].
Activities Associated with Needlestick Injuries
Whenever a needle or other sharp device is exposed, injuries can occur. Data from NaSH show that approximately 38% of percutaneous injuries occur during use and 42% occur after use and before disposal. Causes of percutaneous injuries with hollow-bore needles are shown in Figure 2.
The circumstances leading to a needlestick injury depend partly on the type and design of the device used. For example, needle devices that must be taken apart or manipulated after use (e.g., prefilled cartridge syringes and phlebotomy needle/vacuum tube assemblies) are an obvious hazard and have been associated with increased injury rates [Jagger et al. 1988]. In addition, needles attached to a length of flexible tubing (e.g., winged-steel needles and needles attached to IV tubing) are sometimes difficult to place in sharps containers and thus present another injury hazard. Injuries involving needles attached to IV tubing may occur when a health care worker inserts or withdraws a needle from an IV port or tries to temporarily remove the needlestick hazard by inserting the needle into a drip chamber, IV port or bag, or even bedding.
In addition to risks related to device characteristics, needlestick injuries have been related to certain work practices such as
Past studies of needlestick injuries have shown that 10% to 25% occurred when recapping a used needle [Ruben et al. 1983; Krasinski et al. 1987; McCormick and Maki 1981; McCormick et al. 1991; Yassi and McGill 1991]. Although recapping by hand has been discouraged for some time and is prohibited under the OSHA bloodborne pathogens standard [29 CFR 1910.1030] unless no alternative exists, 5% of needlestick injuries in NaSH hospitals are still related to this practice (Figure 2). Injury may occur when a health care worker attempts to transfer blood or other body fluids from a syringe to a specimen container (such as a vacuum tube) and misses the target. Also, if used needles or other sharps are left in the work area or are discarded in a sharps container that is not puncture resistant, a needlestick injury may result.
Figure 1. Hollow-bore needles and other devices associated with percutaneous injuries in NaSH hospitals, by % total percutaneous injuries (n=4,951), June 1995—July 1999. (Source: CDC .)
Figure 2. Causes of percutaneous injuries with hollow-bore needles in NaSH hospitals, by % total percutaneous injuries (n=3,057), June 1995—July 1999. (Source: CDC .)
OSHA, FDA, AND STATE REGULATIONS**
The current Federal standard for addressing needlestick injuries among health care workers is the OSHA bloodborne pathogens standard [29 CFR 1910.1030; 56 Fed. Reg.†† 64004 (1991)], which has been in effect since 1992. The standard applies to all occupational exposures to blood or other potentially infectious materials. Notable elements of this standard require the following:
OSHA also intends to act to reduce the number of injuries that health care workers receive from needles and other sharp medical objects [OSHA 1999a]. First, the agency has revised the compliance directive (guidance to be used in the field) accompanying its 1992 bloodborne pathogens standard [29 CFR 1910.1030] to reflect newer and safer technologies now available and to increase the employer's responsibility to evaluate and use effective, safer technologies [OSHA 1999b]. Second, the agency has proposed a requirement in the revised recordkeeping rule that all injuries resulting from contaminated needles and sharps be recorded on OSHA logs used by employers to record injuries and illnesses. Finally, OSHA will take steps to amend its bloodborne pathogens standard by placing needlestick and sharps injuries on its regulatory agenda.
Under the regulations of the Food and Drug Administration (FDA) application clearance process [FDA 1995], the manufacturers of medical devices (including needles used in patient care) must meet requirements for appropriate registration and for listing, labeling, and good manufacturing practices for design and production. The process for receiving clearance or approval to market a device requires device manufacturers to (1) demonstrate that a new device is substantially equivalent to a legally marketed device or (2) document the safety and effectiveness of the new device for patient care through a more involved premarket approval process. FDA has also released two advisories pertaining to sharps and the risk of bloodborne pathogen transmission in the health care setting [FDA 1992; FDA et al. 1999].
Currently, three States have adopted and more than two dozen are considering legislation to require additional regulatory actions addressing bloodborne pathogen exposures to health care workers. The recent California standard [State of California 1998] has several requirements that go beyond those currently required by OSHA. These requirements include stronger language for the use of needleless systems for certain procedures or (where needleless systems are not available) the use of needles with engineered sharps injury protection for certain procedures.
The following case reports briefly describe the experiences of five health care workers who developed serious infections after occupational exposures to bloodborne pathogens. Their cases illustrate a number of the preventable hazardous conditions and practices that can lead to needlestick injuries.
A hospitalized patient with AIDS became agitated and tried to remove the intravenous (IV) catheters in his arm. Several hospital staff members struggled to restrain the patient. During the struggle, an IV infusion line was pulled, exposing the connector needle that was inserted into the access port of the IV catheter. A nurse at the scene recovered the connector needle at the end of the IV line and was attempting to reinsert it when the patient kicked her arm, pushing the needle into the hand of a second nurse. The nurse who sustained the needlestick injury tested negative for HIV that day, but she tested HIV positive several months later [American Health Consultants 1992a].
A physician was drawing blood from a patient in an examination room of an HIV clinic. Because the room had no sharps disposal container, she recapped the needle using the one-handed technique. While the physician was sorting waste materials from lab materials, the cap fell off the phlebotomy needle, which subsequently penetrated her right index finger. The physician's baseline HIV test was negative. She began post-exposure prophylaxis with zidovudine but discontinued it after 10 days because of adverse side effects. Approximately 2 weeks after the needlestick, the physician developed flu-like symptoms consistent with HIV infection. She was found to be seropositive for HIV when tested 3 months after the needlestick exposure [American Health Consultants 1992b].
After performing phlebotomy on a patient with AIDS, a health care worker sustained a deep needlestick injury with the used phlebotomy needle. Blood from the collection tube also spilled into the space between the wrist and cuff of the health care worker's gloves, contaminating her chapped hands. The health care worker removed the gloves and washed her hands immediately. She had a negative baseline HIV test and refused zidovudine prophylaxis. Because her patient was not known to have HCV infection and did not have clinical evidence of liver disease, the health care worker did not receive baseline testing for exposure to HCV. Eight months after the incident, the health care worker was hospitalized with acute hepatitis. She was found to be seropositive for HIV 9 months after the incident. Sixteen months after the incident, she tested positive for anti-HCV antibodies and was diagnosed with chronic HCV infection. Her clinical condition continued to deteriorate, and she died 28 months after the needlestick injury [Ridzon et al. 1997].
During bronchoscopy to determine the cause of shortness of breath in a patient infected with HBV, a health care worker sustained a percutaneous injury with a 25-gauge needle while extracting tissue from biopsy forceps. The worker did not receive post-exposure prophylaxis with hepatitis B immune globulin or hepatitis B vaccine. Approximately 15 weeks after the needlestick injury, the worker noted fatigue, malaise, and jaundice. Later, he was found to have abnormal liver enzymes and a positive test for hepatitis B surface antigen, consistent with acute hepatitis B infection. The patient who underwent bronchoscopy was diagnosed with Pneumocystis carinii pneumonia and died 8 months later after he was diagnosed with disseminated Kaposi's sarcoma and overwhelming opportunistic infection. The injured worker had an uncomplicated medical course, and his liver enzymes and his health eventually returned to normal. He later tested negative for hepatitis B surface antigen and positive for hepatitis B surface antibody, indicating recovery from his HBV infection. On followup 15 months after the needlestick injury, the worker also tested HIV negative; serum from the deceased patient was not available for antibody testing [Gerberding et al 1985].
In 1972, a nurse sustained a needlestick injury to her finger while removing a hypodermic needle from a patient's arm. At the time of the injury, the source patient had apparent acute non-A, non-B hepatitis. The nurse developed hepatitis 6 weeks after the needlestick injury. Her liver enzymes remained elevated for nearly a year. Later examination of serum samples from the nurse and the source patient showed that both persons were infected with HCV. The initial serum sample from the nurse in 1972 was negative for anti-HCV antibody, but the sample obtained 6 weeks after the needlestick injury was seropositive. Although the nurse was clinically well at the time of the report, she remained seropositive for HCV [Seeff 1991].
USE OF IMPROVED ENGINEERING CONTROLS IN A PREVENTION STRATEGY
Comprehensive Programs to Prevent Needlestick Injuries
Safety and health issues can best be addressed in the setting of a comprehensive prevention program that considers all aspects of the work environment and that has employee involvement as well as management commitment. Implementing the use of improved engineering controls is one component of such a comprehensive program. Since many devices with needlestick prevention features are new, this section primarily addresses their use, including desirable characteristics, examples, and data supporting their effectiveness. However, other prevention strategy factors that must be addressed include modification of hazardous work practices, administrative changes to address needle hazards in the environment (e.g., prompt removal of filled sharps disposal boxes), safety education and awareness, feedback on safety improvements, and action taken on continuing problems. Several authors have noted the importance of a comprehensive approach [Krasinski et al. 1987; Hanrahan and Reutter 1997; DeJoy et al. 1995; Ramos-Gomez et al. 1997; Gershon et al. 1995]. The critical role of appropriate training has been emphasized by several recent reports of increased patient bloodstream infections associated with improper care of needleless IV systems, primarily in the home health care setting [Cookson et al. 1998; Danzig et al. 1995; Do et al. 1999; Kellerman et al. 1996]. These data emphasize the need for patient safety surveillance and thorough training as well as occupational injury surveillance when implementing the use of a new medical device.
Case Study of a Successful Comprehensive Prevention Program
The value of a comprehensive approach is illustrated by its success in a recent report by Dale et al. . Between 1993 and 1996, the phlebotomy service at a major institution decreased the needlestick injury rate among its 200 full-time phlebotomists from 1.5 to 0.2 per 10,000 venipunctures performed. In comparison, a national survey from 1990 to 1992 found a median needlestick injury rate of about 0.94 per 10,000 venipunctures [Howanitz and Schifman 1994]. A retrospective review of the events contributing to the success of the phlebotomy service included changes in worker education and work practices, the implementation of devices with safety features, and encouragement of injury reporting. These interventions as well as the implementation of CDC published guidelines and the OSHA bloodborne pathogens standard were associated with the observed steady decline in the injury rate. The authors noted that an important factor contributing to this success was a thorough understanding of the injuries that occurred among their staff.
Desirable Characteristics of Devices with Safety Features
Improved engineering controls are often among the most effective approaches to reducing occupational hazards and therefore are an important element of a needlestick prevention program. Such controls include eliminating the unnecessary use of needles and implementing devices with safety features. A number of sources have identified the desirable characteristics of safety devices [OSHA 1999c; FDA 1992; Jagger et al. 1988; Chiarello 1995; Quebbeman and Short 1995; Pugliese 1998; Fisher 1999; ECRI 1999]. These characteristics include the following:
Although each of these characteristics is desirable, some are not feasible, applicable or available for certain health care situations. For example, needles will always be necessary where alternatives for skin penetration are not available. Also, a safety feature that requires activation by the user might be preferable to one that is passive in some cases. Each device must be considered on its own merit and ultimately on its ability to reduce workplace injuries. The desirable characteristics listed here should thus serve only as a guideline for device design and selection.
Examples of Safety Device Designs
Figure 3 shows examples of syringes with safety features. These and other examples of safety device designs are listed as follows:
Figure 3. Three examples of syringes with safety features. (These drawings are presented for educational purposes and do not imply endorsement of a particular product by NIOSH.)
Evidence of Effectiveness
Accumulating evidence indicates that devices with safety features reduce needlestick injuries:
Other studies also document substantial reductions in needlestick injuries with the proper use of needleless systems or newer safety needle devices used in a comprehensive program to prevent needlestick injuries [NCCC and DVA 1997; Zafar et al. 1997].
Although the focus in this section is on needle devices with safety features, sharps disposal containers are also important engineering controls to consider in a comprehensive needlestick injury prevention program. NIOSH  recently reviewed the proper location, use, and benefits of sharps disposal containers.
As illustrated by the examples listed here, many devices with safety features decrease the frequency of needlestick injuries, but for many reasons they do not completely eliminate the risk. In some cases, the safety feature cannot be activated until after the needle is removed from the patient. Or the needle may be inadvertently dislodged during a procedure, thereby exposing the unprotected sharp. Some health care workers fail to activate the safety feature, or the safety feature may fail. With some devices, users can bypass safety features. For example, even with some needleless IV delivery systems, a needle can be used to connect parts of the system. Understanding the factors that influence the safety of a device and promoting practices that will maximize prevention effectiveness are therefore important components in prevention planning.
Needlestick injuries are an important and continuing cause of exposure to serious and fatal diseases among health care workers. Greater collaborative efforts by all stakeholders are needed to prevent needlestick injuries and the tragic consequences that can result. Such efforts are best accomplished through a comprehensive program that addresses institutional, behavioral, and device-related factors that contribute to the occurrence of needlestick injuries in health care workers. Critical to this effort are the elimination of needle-bearing devices where safe and effective alternatives are available and the development, evaluation, and use of needle devices with safety features.
Selecting and Evaluating Needle Devices with Safety Features
An increasing number and variety of needle devices with safety features are now available, but many of these devices have had only limited use in the workplace. Thus health care organizations and workers may find it difficult to select appropriate devices. Although these devices are designed to enhance the safety of health care workers, they should be evaluated to ensure that
As employers implement the use of needle devices with safety features, they can use several guidelines to select and evaluate these products. These guidelines are derived partly from publications and other resources offering plans, evaluation forms, and related information in this new area [Chiarello 1995; Fisher 1999; SEIU 1998; EPINet 1999; Pugliese and Salahuddin 1999]. While health care settings are implementing the use of needle devices with safety features, they should seek help from the appropriate professional organizations, trade groups, and manufacturers in obtaining information about devices and procedures suitable for specific settings (e.g. dental offices). Other information sources are listed in later sections of the Alert (see References, Additional Information, and Suggested Readings). In addition, OSHA received nearly 400 responses to its recent public request for information about preventing occupational exposure to bloodborne pathogens from percutaneous injuries [63 Fed. Reg. 48250 (1998); OSHA 1999c]. This information includes numerous reports about the successful implementation of needlestick injury prevention programs, and it may be useful to medical institutions as they establish injury tracking systems, prevention approaches, and the use of safer devices.
The major elements of a process for selecting and evaluating needle devices with safety features are listed here briefly:
Ongoing review of current devices and options will be necessary. As with any evolving technology, the process will be dynamic, and with experience, improved devices with safety features will emerge.
Recommendations for Employers
To protect health care workers from needlestick injuries, employers must provide a safe working environment that includes safer needle devices and effective safety programs. Many types of needle devices are associated with needlestick injuries, and these injuries can occur in many ways. Thus a combination of prevention strategies must be considered. Employers should take the following steps to implement a program for reducing needlestick injuries and to involve workers in this effort.
Recommendations for Workers
To protect themselves and their coworkers, health care workers should be aware of the hazards posed by needlestick injuries and should use safety devices and improved work practices as follows:
For additional information about needlestick injuries, call 1-800-35-NIOSH (1-800-356-4674); or visit the NIOSH Web site at http://www.cdc.gov/niosh/homepage.html.
The following Web sites provide additional information about needlestick injuries and safer needle devices:
Principal contributors to this Alert were Thomas K. Hodous, M.D.; Linda A. Chiarello, R.N., M.S.; Scott D. Deitchman, M.D., M.P.H; Ann N. Do, M.D.; Anne C. Hamilton; Janice M. Huy, M.S.; E. Lynn Jenkins, M.A.; Andrew M. Maxfield, Ph.D.; Edward L. Petsonk, M.D.; Raymond C. Sinclair, Ph.D.; and Angela M. Weber, M.S.
Please direct comments, questions, or requests for additional information to the following:
Director, Division of Safety Research
National Institute for Occupational Safety
1095 Willowdale Road
Morgantown, WV 26505
Telephone, 304-285-5894; or call
We greatly appreciate your assistance in protecting the health of U.S. workers.
Linda Rosenstock, M.D., M.P.H.
Director, National Institute for
Occupational Safety and Health
Centers for Disease Control
Alter MJ . Epidemiology of hepatitis C in the west. Semin Liver Dis 15(1):5—14.
Alter MJ . The epidemiology of acute and chronic hepatitis C. Clin Liver Dis 1(3):559—569.
American Health Consultants [1992a]. Court awards $5.37 million to occupationally infected nurse. AIDS Alert Oct:149—152.
American Health Consultants [1992b]. Occupationally infected doctor says exposure was preventable. AIDS Alert Aug:118—119.
Armstrong K, Gorden R, Santorella G . Occupational exposure of health care workers (HCWs) to human immunodeficiency virus (HIV): stress reactions and counseling interventions. Soc Work Health Care 21(3):61—80.
Bell DM . Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 102 (Suppl 5B):9—15.
Billiet LS, Parker CR, Tanley PC, Wallas CH . Needlestick injury rate reduction during phlebotomy; a comparative study of two safety devices. Lab Med 22(2):122—123.
Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, Heptonstall J, Ippolito G, Lot F, McKibben PS, Bell DM, CDC Needlestick Surveillance Group . A case-control study of HIV seroconversion in health care workers after percutaneous exposure. New Engl J Med 337(21):1485—1490.
CDC (Centers for Disease Control and Prevention) [1997a]. Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy proceduresMinneapolis-St.Paul, New York City, and San Francisco, 19931995. MMWR 46(2):21—25.
CDC (Centers for Disease Control and Prevention) [1997b]. Immunization of health care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 46(RR18):1—42.
CDC (Centers for Disease Control and Prevention) [1998a]. U.S. HIV and AIDS cases reported through December 1998. HIV/AIDS Surveillance Report 10(2):26.
CDC (Centers for Disease Control and Prevention) [1998b]. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 47(RR19): 1—39.
CDC (Centers for Disease Control and Prevention) [1998c]. Public Health Service guidelines for the management of health care worker exposures to HIV and recommendations for postexposure prophylaxis. MMWR 47(RR7).
CDC (Centers for Disease Control and Prevention) [1998d]. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR 47(RR5).
Chiarello LA . Selection of needlestick prevention devices: a conceptual framework for approaching product evaluation. Am J Infect Control 23(6):386—395.
CFR. Code of Federal Regulations. Washington, DC: U.S. Government Printing Office, Office of the Federal Register.
Cookson ST, Ihrig M, OMara EM, Denny M, Volk H, Banerjee SN, Hartstein AI, Jarvis WR . Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol 19(1):23—27.
Dale JC, Pruett SK, Maker MD . Accidental needlestick in the Phlebotomy Service of the Department of Laboratory Medicine and Pathology at Mayo Clinic Rochester. Mayo Clin Proc 73(7):611—615.
Danzig LE, Short LJ, Collins K, Mahoney M, Sepe S, Bland L, Jarvis WR . Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. JAMA 273(23):1862—1864.
DeJoy DM, Murphy LR, Gershon RM . The influence of employee, job/ task, and organizational factors on adherence to universal precautions among nurses. Int J Ind Ergonomics 16:43—55.
Do AN, Ray BJ, Banerjee SN, Illian AF, Barnett BJ, Pham MH, Hendricks KA, Jarvis WR . Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 179:442—448.
ECRI . Needlestick-prevention devices. Health Devices 28(10):381—407.
EPINet . Exposure prevention information network data reports. University of Virginia: International Health Care Worker Safety Center.
FDA . FDA safety alert: needlestick and other risks from hypodermic needles on secondary I.V. administration sets piggyback and intermittent I.V. Rockville, MD: Food and Drug Administration.
FDA . FDA supplementary guidance on the content of premarket notification [510 (K)] submissions for medical devices with sharps injury prevention features. Rockville, MD: Food and Drug Administration.
FDA, NIOSH, OSHA . Glass capillary tubes: joint safety advisory about potential risks. Rockville, MD: Food and Drug Administration. [www.cdc.gov/niosh/capssa9.html]. Date accessed: May 28, 1999.
56 Fed. Reg. 64004 . Occupational Safety and Health Administration: final rule on occupational exposure to bloodborne pathogens.
63 Fed. Reg. 48250 . Occupational Safety and Health Administration: final rule on occupational exposure to bloodborne pathogens: request for information, Docket No. H370A.
Fisher J . Training for development of innovative control technology project. San Francisco, CA: San Francisco General Hospital.
Gartner K . Impact of a needleless intravenous system in a university hospital. Am J Infect Control 20:75—79.
Gerberding JL . Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 170(6):1410—1417.
Gerberding JL, Hopewell PC, Kaminsky LS, Sande MA . Transmission of hepatitis B without transmission of AIDS by accidental needlestick. N Engl J Med 312(1):56.
Gershon RM, Vlahov D, Felknor SA, Vesley D, Johnson PC, Delclos GL, Murphy LR . Compliance with universal precautions among health care workers at three regional hospitals. Am J Infect Control 23(4):225—236.
Hanrahan A, Reutter L . A critical review of the literature on sharps injuries: epidemiology, management of exposures and prevention. J Adv Nurs 25:144—154.
Henry K, Campbell S . Needlestick/sharps injuries and HIV exposures among health care workers: national estimates based on a survey of U.S. hospitals. Minn Med 78:1765—1768.
Henry K, Campbell S, Jackson B, Balfour H, Rhame F, Sannerud K, Pollack S, Sninsky J, Kwok S . Long-term follow-up of health care workers with work-site exposure to human immunodeficiency virus [letter to the editor]. JAMA 263(13):1765—1766.
Howanitz PJ, Schifman RB . Phlebotomists safety practices: a College of American Pathologists Q-Probes study of 683 institutions. Arch Pathol Lab Med 118:957—962.
Ihrig M, Cookson ST, Campbell K, Hartstein AI, Jarvis WR . Evaluation of the acceptability of a needleless vascular-access system by nurses. Am J Infect Control 25(5):434—438.
International Health Care Worker Safety Center . Uniform needlestick and sharp-object injury report 1996, 65 hospitals. Adv Exposure Prev 3(2):15—16.
Ippolito G, Puro V, Heptonstall J, Jagger J, De Carli G, Petrosillo N . Occupational human immunodeficiency virus infection in health care workers: worldwide cases through September 1997. Clin Infect Dis 28:365—383.
Jagger J . Reducing occupational exposure to bloodborne pathogens: where do we stand a decade later? Infect Control Hosp Epidemiol 17(9):573—575.
Jagger J, Hunt EH, Brand-Elnagger J, Pearson RD . Rates of needle-stick injury caused by various devices in a university hospital. N Engl J Med 319(5): 284—288.
Kellerman S, Shay DK, Howard J, Goes C, Feusner J, Rosenberg J, Vugia DJ, Jarvis WR . Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. J Pediatr 129(5):711—717.
Krasinski K, LaCouture R, Holzman RS . Effect of changing needle disposal systems on needle puncture injuries. Infect Control 8(2):59—62.
Lawrence LW, Delclos GL, Felknor SA, Johnson PC, Frankowski RF, Cooper SP, Davidson A . The effectiveness of a needleless intravenous connection system: an assessment by injury rate and user satisfaction. Infect Control Hosp Epidemiol 18(3):175—182.
McCormick RD, Maki DG . Epidemiology of needle-stick injuries in hospital personnel. Am J Med 70:928—932.
McCormick RD, Meisch MG, Ircink FG, Maki DG . Epidemiology of hospital sharps injuries: a 14-year prospective study in the pre-AIDS and AIDS eras. Am J Med 91(Suppl 3B):301S—307S.
Murphy LR, Gershon RM, Dejoy D . Stress and occupational exposure to HIV/AIDS. In: Cooper CL, ed. Handbook of stress, medicine, and health. Boca Raton, FL: CRC Press, pp. 177—190.
NCCC, DVA . Needle stick prevention in the Department of Veterans Affairs; 1996 follow-up survey results. Milwaukee, WI: National Center for Cost Containment and Department of Veterans Affairs.
NIOSH . Selecting, evaluating, and using sharps disposal containers. Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 97—111.
Osborn EHS, Papadakis MA, Gerberding JL . Occupational exposures to body fluids among medical students. A seven-year longitudinal study. Ann Intern Med 130(1):45—51.
OSHA [1999a]. National news release: Labor Secretary announces plans to combat needlestick injuries among healthcare workers. Washington, DC: U.S. Department of Labor, Occupational Safety and Health Administration, USDL 99—145.
OSHA [1999b]. OSHA Directives 2-2.44D Enforcement procedures for the occupational exposure to bloodborne pathogens. Washington, DC: U.S. Department of Labor, Occupational Safety and Health Administration. [www.osha-slc.Gov/OshDoc/Directive _data/CPL_2-2_44D.html]. Date accessed: November 11, 1999.
OSHA [1999c]. Record summary of the request for information on occupational exposure to bloodborne pathogens due to percutaneous injury. Washington, DC: U.S. Department of Labor, Occupational Safety and Health Administration. [www. osha-slc.gov/html/ndlreport052099.html]. Date accessed: August 9, 1999.
Polish LB, Tong MJ, Co RL, Coleman PJ, Alter MJ . Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 21(4):196—200.
Pugliese G, ed. . Using safer needle devices: the time is now. Report of the National Committee on Safer Needle Devices. Arlington, TX: Johnson & Johnson Medical.
Pugliese G, Salahuddin M, eds. . Sharps injury prevention program: a step-by-step guide. Chicago, IL: American Hospital Association.
Quebbeman EJ, Short LJ . How to select and evaluate new products on the market. Surg Clin North Am 75(6):1159—1165.
Ramos-Gomez F, Ellison J, Greenspan D, Bird W, Lowe S, Gerberding JL . Accidental exposures to blood and body fluids among health care workers in dental teaching clinics: a prospective study. J Am Dent Assoc 128:1253—1261.
Ridzon R, Gallagher K, Ciesielski C, Mast EE, Ginsberg MB, Robertson BJ, Luo C, DeMaria A Jr. . Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med 336(13):919—922.
Roy E, Robillard P . Underreporting of accidental exposures to blood and other body fluids in health care settings = an alarming situation (abstract). Adv Exposure Prev 1(4):11.
Ruben FL, Norden CW, Rockwell K, Hruska E . Epidemiology of accidental needle-puncture wounds in hospital workers. Am J Med Sci 286(1):26—30.
Seeff LB . Hepatitis C from a needle-stick injury. Ann Intern Med 115(5):411.
SEIU . SEIUs guide to preventing needlestick injuries. 3rd ed. Washington, DC: Service Employees International Union.Shapiro CN . Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am 75(6):1047—1056.
State of California . California proposed emergency standard: 5193; bloodborne pathogens. Sacramento, CA. [www. Dir.ca.gov/DIR/OS&H/OSHSB/bloodborne.html]. Date accessed: December 21, 1998.
Yassi A, McGill M . Determinants of blood and body fluid exposure in a large teaching hospital: hazards of the intermittent intravenous procedure. Am J Infect Control 19(3):129—135.
Yassi A, McGill ML, Khokhar JB . Efficacy and cost-effectiveness of a needleless intravenous access system. Am J Infect Control 23(2):57—64.
Zafar AB, Butler RC, Podgorny JM, Mennonna PA, Gaydos LA, Sandiford JA . Effect of a comprehensive program to reduce needlestick injuries. Infect Control Hosp Epidemiol 18(10):712—715.
Association for Professionals in Infection Control and Epidemiology, Inc. . APIC position paper: prevention of device-mediated bloodborne infections to health care workers. Am J Infect Control 26: 578—580.
Charney W (ed.) . Essentials of modern hospital safety. Vol. 3. Ann Arbor, MI: CRC Press.
Cone JE, Hagadone K, Boyd A . The epidemiology of sharps injuries. In: The epidemic of health care worker injury: an epidemiology. Charney and Fragala, eds. New York, NY: CRC Press.
ECRI . Needlestick-prevention devices. Health Devices 27:183—232.
OSHA . Safer needle devices: protecting health care workers. Washington, DC: U.S. Department of Labor, Occupational Safety and Health Administration, Directorate of Technical Support.
OSHA . How to prevent needlestick injuries: answers to some important questions. Washington, DC: U.S. Department of Labor, Occupational Safety and Health Administration.
OSHA . Occupational exposure to bloodborne pathogens. Washington, DC: U.S. Department of Labor, Occupational Safety and Health Administration, OSHA, #3127 (Revised).
Porta C, Handelman E, McGovern P . Needlestick injuries among health care workers: a literature review. Am Assoc Occup Health Nur J 47(6):237—244.
Mention of any company or product does not constitute endorsement by the National Institute for Occupational Safety and Health.
This document is in the public domain and may be freely copied or reprinted.
Disclaimer: Mention of any company or product does not constitute endorsement by NIOSH.
Copies of this and other NIOSH documents are available from National Institute for Occupational Safety and Health
4676 Columbia Parkway
Cincinnati, OH 45226-1998
Fax number: (513) 533-8573
Telephone number: 1-800-35-NIOSH (1-800-356-4674)
To receive other information about occupational safety and health
problems, call 1-800-35-NIOSH (1-800-356-4674), or visit the NIOSH Home Page
on the World Wide Web at http://www.cdc.gov/niosh/homepage.htmlDHHS (NIOSH)Publication No. 2000-108 November 1999
This page was last updated on November 22, 1999